Pitavastatin Calcium
Brand name: Livalo
Rank #288 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$40.8M
Total Cost
69,636
Total Claims
$40.8M
Total Cost
3,199
Prescribers
$587
Cost per Claim
3,677
Beneficiaries
128,513
30-Day Fills
$13K
Avg Cost/Provider
22
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$40.8M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $40.8M total
🔎 Data Overview
Average cost of $11,109 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Pitavastatin Calcium
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Gary Reznik | Cardiology | Los Angeles, CA | 1,617 | $596K |
| 2 | Afshine Emrani | Cardiology | Tarzana, CA | 653 | $369K |
| 3 | Anna Milstein | Cardiology | Los Angeles, CA | 626 | $230K |
| 4 | Zhengnan Yin | Family Practice | Houston, TX | 238 | $209K |
| 5 | Edwin Yau | Family Practice | Monterey Park, CA | 515 | $189K |
| 6 | Eddie Lim | Internal Medicine | Honolulu, HI | 260 | $160K |
| 7 | Don Lee | Interventional Cardiology | Glendale, CA | 299 | $154K |
| 8 | Nathaniel Lebowitz | Cardiology | Fort Lee, NJ | 174 | $140K |
| 9 | Lynn Xu | Nurse Practitioner | Monterey Park, CA | 259 | $131K |
| 10 | Raveen Arora | Cardiology | Anaheim, CA | 175 | $120K |
| 11 | Joyce Yeung | Nurse Practitioner | Brooklyn, NY | 192 | $113K |
| 12 | Rui Er Teng | Family Practice | Brooklyn, NY | 129 | $110K |
| 13 | Vlad Nusinovich | Internal Medicine | West Hollywood, CA | 315 | $109K |
| 14 | Kuocheng Wang | Internal Medicine | New York, NY | 239 | $106K |
| 15 | Yili Huang | Cardiology | Elmhurst, NY | 160 | $92K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 285 | Travoprost (Travoprost) | $41.5M | 178,599 |
| 286 | Alendronate Sodium (Alendronate Sodium) | $41.4M | 3,414,824 |
| 287 | Daptomycin (Daptomycin) | $41.2M | 41,245 |
| 288 | Pitavastatin Calcium (Livalo) | $40.8M | 69,636 |
| 289 | Bromfenac Sodium (Prolensa) | $40.8M | 121,284 |
| 290 | Suvorexant (Belsomra) | $40.7M | 87,327 |
| 291 | Atogepant (Qulipta) | $40.7M | 32,955 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology